NCT00127998View on ClinicalTrials.gov

Antimalarial Drug Resistance in Mali

NACompletedINTERVENTIONAL
Enrollment

1,011

Participants

Timeline

Start Date

July 31, 2005

Conditions
Malaria
Interventions
DRUG

chloroquine

DRUG

sulfadoxine-pyrimethamine

DRUG

amodiaquine

DRUG

amodiaquine+artesunate

DRUG

amodiaquine+sulfadoxine-pyrimethamine

DRUG

sulfadoxine-pyrimethamine+artesunate

DRUG

artemether-lumefantrine

DRUG

mefloquine

Trial Locations (3)

Unknown

Faladje Missionary Dispensary, Faladié

Koro Health Center, Koro

Pongono Community Health Center, Pongono

All Listed Sponsors
collaborator

Malaria Research and Training Center, Bamako, Mali

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT00127998 - Antimalarial Drug Resistance in Mali | Biotech Hunter | Biotech Hunter